Lv12
90 积分 2025-04-21 加入
0567 Tirzepatide for the Treatment of OSA: Rationale and Design of the SURMOUNT-OSA Phase 3 Trial
10天前
已完结
In adults with moderate-to-severe OSA and obesity, tirzepatide reduced apnea–hypopnea events vs. placebo
10天前
已完结
GLP1 agonists: current and future landscape of clinical trials for patients with metabolic dysfunction
11天前
已完结
Associations between Class I, II, or III Obesity and Health Outcomes
17天前
已完结
Health Complications of Obesity
18天前
已完结
皖公网安备34019202002308
